Increases in Circulating Levels of Ketone Bodies and Cardiovascular Protection With SGLT2 Inhibitors: Is Low-Grade Inflammation the Neglected Component? - Prattichizzo, F; De Nigris, V; Micheloni, S (Diabetes Obes Metab, 2018)
et al.